http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015202351-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9af92f4554db5d1aa6de217b6a3c1952 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 |
filingDate | 2015-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aac4e562e1e25597ce178f7dea552857 |
publicationDate | 2015-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2015202351-A1 |
titleOfInvention | Anti-inflammatory antibodies and uses therefor |
abstract | INHIBITING PEPTIDES DERIVED FROM TREM-LIKE TRANSCRIPT 1 (TLT-1) AND USES THEREOF The present invention relates to polypeptides fragments derived from the protein TLT- 1 and their 5 uses for the treatment of inflammatory conditions and more particularly for the treatment of sepsis. |
priorityDate | 2009-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 317.